ERBB2 and neoplasm: Established pathological factors include tumor size, involvement of axillary lymph nodes, histologically verified estrogen receptor (ER) and progesterone receptor (PR) status, human epidermal growth factor receptor 2 (HER2) expression and Ki-67 [1].